Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.
about
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistanceEffect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.Cell signaling and receptors with resorcinols and flavonoids: redox, reactive oxygen species, and physiological effects.Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events.Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
P2860
Q24648189-36E8ABB8-9650-4F4D-B196-33A829958D9BQ33857214-720069AC-1C83-435C-81C0-1D44FF2255A6Q33858526-F018FE1E-B641-4E0F-AE1E-D8D37C94131AQ33873730-4278D02B-A356-4199-9028-519B9AB9DC32Q33882617-0B1F53BA-8BD1-46C6-A093-2AB439ACDE11Q37899908-82C87E76-C14D-44D4-88EE-939D18ADF2A2Q42151368-4F55EF5F-F7D4-46EF-805D-FA56A964B119Q53160636-ECABE00B-FF35-447E-BD0A-6C4B81FA9353Q54113356-8DFADBB7-30C8-4479-B97E-DEEB97E4B8F9
P2860
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Inhibition of apoB secretion f ...... ndent of the insulin receptor.
@en
type
label
Inhibition of apoB secretion f ...... ndent of the insulin receptor.
@en
prefLabel
Inhibition of apoB secretion f ...... ndent of the insulin receptor.
@en
P2093
P2860
P1476
Inhibition of apoB secretion f ...... ndent of the insulin receptor.
@en
P2093
Emma M Allister
Erin E Mulvihill
Jane Y Edwards
Lindsey P Carter
Murray W Huff
P Hugh R Barrett
P2860
P304
P356
10.1194/JLR.M800297-JLR200
P577
2008-06-27T00:00:00Z